Cargando…

Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC

Detalles Bibliográficos
Autor principal:	Donington, Jessica S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646054/ https://www.ncbi.nlm.nih.gov/pubmed/34917990 http://dx.doi.org/10.1016/j.jtocrr.2021.100240

Ejemplares similares

Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC
por: Donington, Jessica S.
Publicado: (2022)

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
por: Antonoff, Mara B., et al.
Publicado: (2022)

Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples
por: Esteves, Sandro C., et al.
Publicado: (2017)

Update on adjuvant therapy in completely resected NSCLC patients
por: Lim, Jeong Uk, et al.
Publicado: (2021)

First-line immune-chemotherapy combination for squamous NSCLC is already a reality
por: Hendriks, Lizza E. L., et al.
Publicado: (2020)

New data: new options for front-line therapy in NSCLC?
por: Reinmuth, Niels
Publicado: (2018)

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC
por: Lee, Jay M., et al.
Publicado: (2021)

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Prognostic Factors and Long-Term Survival in Locally Advanced NSCLC with Pathological Complete Response after Surgical Resection Following Neoadjuvant Therapy
por: Lococo, Filippo, et al.
Publicado: (2020)

Lung resection surgery in Jehovah’s Witness patients: a 20-year single-center experience
por: Lee, Andy Chao Hsuan, et al.
Publicado: (2022)

Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?
por: Gravara, Luigi Della, et al.
Publicado: (2020)

Surgical Resection Versus Stereotactic Body Radiation Therapy for Stage I NSCLC: Can Randomized Trials Provide the Solution?
por: Subramanian, Melanie P., et al.
Publicado: (2018)

Population-Based Outcomes in NSCLC
por: Edelman, Martin J
Publicado: (2019)

New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2017)

The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study
por: Phillips, Joseph D., et al.
Publicado: (2023)

NSCLC metastasis: going with ELMO3
por: Goyette, Marie-Anne, et al.
Publicado: (2014)

Avelumab demonstrates promise in advanced NSCLC
por: Marciscano, Ariel E., et al.
Publicado: (2017)

Immunotherapy and NSCLC: The Long and Winding Road
por: Rossi, Antonio
Publicado: (2020)

Surgical resection of spinal teratomas, when the enemy of good surgical outcome can be trying for better?
por: Arvin, Babak
Publicado: (2016)

A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection
por: Hu, Chunhong, et al.
Publicado: (2022)

Implantable biomaterials to provide local immunotherapy following surgical resection
por: Gough, Michael J., et al.
Publicado: (2018)

Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited
por: Denis, Marc G., et al.
Publicado: (2023)

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
por: Chung, Jin Wook
Publicado: (2018)

Long-Term Recurrence of Completely Resected NSCLC
por: Masago, Katsuhiro, et al.
Publicado: (2020)

New Insights into Immune-Based Diagnosis, Therapy and Prophylaxis for Infectious Diseases 2020
por: Sautto, Giuseppe A., et al.
Publicado: (2021)

Surgical perception of lower tracheal or carinal resection
por: Sugita, Yusuke, et al.
Publicado: (2021)

The value of extended glioblastoma resection: Insights from randomized controlled trials
por: Gonda, David D., et al.
Publicado: (2013)

Antiplatelet therapy and bladder tumor resection
por: Goel, Apul, et al.
Publicado: (2018)

Neoadjuvant therapy for resectable pancreatic cancers
por: Inoue, Yosuke, et al.
Publicado: (2022)

Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic
por: Kumar, Sameera, et al.
Publicado: (2020)

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
por: Zhang, Chao, et al.
Publicado: (2022)

Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic?
por: Milner, Ross, et al.
Publicado: (2020)

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)

Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
por: Kim, Bo Hyun
Publicado: (2022)

Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?
por: Kim, Dong Uk
Publicado: (2023)

The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
por: Aldea, Mihaela, et al.
Publicado: (2020)

Surgical resection and survival of patients with unsuspected single node positive lung cancer (NSCLC) invading the descending aorta
por: Wex, Peter, et al.
Publicado: (2009)

Scientific integrity at Science Advances: Essential pillar supporting scientific progress
por: Yeagle, Philip
Publicado: (2021)

Is mechanical loading essential for exercise to preserve the aging immune system?
por: Simpson, Richard J., et al.
Publicado: (2021)

Perspective on the Cardiotoxicity of Third-Generation Targeted EGFRs in the Treatment of NSCLC
por: Ewer, Michael S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1s6n53kbsl5b2eqsbg9mcbrh17